What Is NAD+? The Essential Coenzyme Explained
NAD+ is the electron carrier at the centre of energy metabolism and the required substrate for the enzymes that repair DNA and regulate gene expression. A precise account.
The Short Answer
NAD+, nicotinamide adenine dinucleotide, is a coenzyme present in every living cell that performs two distinct jobs. As a redox carrier it accepts and donates electrons, cycling between NAD+ and NADH, which is how energy from food is transferred into ATP production. As a consumed substrate it is cleaved by three enzyme families, sirtuins, PARPs and CD38, which use it to regulate gene expression, repair DNA and signal within the immune system. Tissue NAD+ declines with age in multiple mammalian tissues, driven more by increased consumption than by reduced synthesis, and that decline is the basis for the entire NAD+ supplement category.
The Two Jobs
Job one: electron carrier. In glycolysis, in the citric acid cycle and in fatty acid oxidation, NAD+ accepts electrons to become NADH. NADH then delivers those electrons to complex I of the mitochondrial electron transport chain, where they drive proton pumping and, ultimately, ATP synthesis. In this role NAD+ is not consumed; it is recycled continuously, and the ratio of NAD+ to NADH reports the cell's oxidative state.
Job two: consumed substrate. Three enzyme families cleave NAD+ rather than recycling it, releasing nicotinamide in the process.
- Sirtuins use it to remove acetyl groups from proteins, altering gene expression, mitochondrial function and metabolic adaptation.
- PARPs use it to attach ADP-ribose chains to proteins in response to DNA strand breaks, coordinating repair.
- CD38 and related enzymes use it in immune signalling, generating calcium-mobilising messengers.
This second job is what makes NAD+ a limited resource rather than a permanent fixture. Every DNA repair event and every sirtuin reaction spends some, and the pool must be continuously resynthesised.
How the Body Makes It
Three pathways converge on NAD+.
The salvage pathway does most of the work, recycling the nicotinamide released by NAD+-consuming enzymes. NAMPT converts nicotinamide to NMN, and NMNAT enzymes convert NMN to NAD+. NAMPT is the rate-limiting step, its expression is under circadian control, and it declines in several tissues with age.
The Preiss-Handler pathway starts from nicotinic acid, converting it through nicotinic acid mononucleotide and nicotinic acid adenine dinucleotide to NAD+.
The de novo pathway builds NAD+ from tryptophan through the eight-step kynurenine cascade. It is metabolically expensive, is diverted by inflammatory signalling, and contributes a minority of the total.
Because the salvage pathway dominates and NAMPT is its bottleneck, precursors entering downstream of NAMPT, meaning NR and NMN, are the mechanistic basis for the supplement category.
Why It Declines With Age
NAD+ concentration is synthesis minus consumption, and the evidence points more strongly to rising consumption than to falling synthesis as the main driver of age-related decline.
CD38 activity rises. This enzyme, expressed on immune cells, increases with inflammatory signalling and with age, and it is a major NAD+ sink. Chronic low-grade inflammation therefore drains the pool continuously.
PARP activity rises. Accumulated DNA damage means more repair activity, and each repair event consumes NAD+. Ultraviolet exposure and tobacco smoke both increase this drain directly.
NAMPT expression falls in several tissues, reducing salvage capacity, and circadian disruption flattens its oscillation.
The practical implication of this arithmetic is under-discussed: lowering inflammatory load, protecting against ultraviolet exposure, not smoking, sleeping regularly and exercising, which raises NAMPT expression in muscle, all act on the same problem as a precursor supplement and in some cases more effectively.
Can It Be Raised, and Does It Help?
Raising blood NAD+ in humans is straightforward. NR at 250 to 1,000 mg per day and NMN at 250 to 900 mg per day both do so reliably, and nicotinic acid does so at a fraction of the cost with flushing as the trade-off.
Whether that produces benefit is the unresolved question, and two findings should shape expectations. Several well-conducted trials found no increase in muscle NAD+ content despite large increases in blood, indicating that tissue distribution is uneven and that blood is the convenient measurement rather than the relevant one. And functional trials in healthy adults have largely been null, with the positive signals concentrated in populations starting from a compromised metabolic baseline.
That pattern suggests NAD+ repletion behaves more like correcting an inadequate state than like enhancing a normal one, which is a considerably narrower proposition than the category is marketed on.
Measuring NAD+
Whole blood and intracellular NAD+ assays exist and are used in research, and some consumer services offer them. Interpretation is limited for three reasons: reference ranges are not well established, blood values may not reflect the tissue relevant to a given objective, and sample handling matters because NAD+ degrades.
There is no accessible way for an individual to measure NAD+ in muscle, brain or liver, which is where the interesting questions sit. This means that anyone supplementing a precursor is generally acting without a usable readout, and it is one reason a defined observation window and a functional endpoint matter more here than a biomarker.
The AEONNN Perspective
NAD+ sits at the centre of Cellular Energy and Repair, Pillar 1, and it is one of the clearest illustrations of why AEONNN reasons across Pillars rather than compound by compound. NAD+ status depends on inflammatory load in Pillar 3, sleep and circadian regularity in Pillar 9, and training in Pillar 1 itself, because all three affect the consumption side and the salvage capacity.
Stack Builder handles precursors as a single functional slot and audits the rest of a member's stack for overlapping nicotinamide from multivitamins and B-complexes, since nicotinamide inhibits sirtuins at higher concentrations and can work against the intended effect. That check requires reasoning across products rather than within them.
Insight Protocol also states the confidence honestly: strong for blood NAD+ elevation, weak for functional outcomes in healthy adults. For many members the highest-value NAD+ intervention is not a capsule, and a platform that could not reach that conclusion would be selling substrate to people whose problem is consumption.
Pillar Matrix mapping
Database Matrix layers
- Mechanistic Layer (KEGG, Reactome, UniProt)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Pharmacokinetics Layer (HMDB, PubChem)
Frequently Asked
What does NAD+ do?
Two things. As a redox carrier it shuttles electrons in energy metabolism, cycling between NAD+ and NADH. As a consumed substrate it is cleaved by sirtuins, PARPs and CD38, which use it for gene regulation, DNA repair and immune signalling.
Why does NAD+ decline with age?
Primarily because consumption rises. CD38 activity increases with inflammatory signalling, PARP activity increases with accumulated DNA damage, and NAMPT expression falls in several tissues, reducing salvage capacity.
What is the difference between NAD+ and NADH?
They are the oxidised and reduced forms of the same molecule. NAD+ accepts electrons to become NADH, which then delivers them to the mitochondrial electron transport chain. The ratio between them reports the cell oxidative state.
Can NAD+ be taken directly as a supplement?
Oral NAD+ itself is not a practical route, since it is degraded and poorly absorbed intact. Supplementation uses precursors that enter the synthesis pathways: nicotinamide riboside, nicotinamide mononucleotide, nicotinic acid or nicotinamide.
Does raising blood NAD+ raise it in tissues?
Not reliably. Several trials found no increase in muscle NAD+ despite large increases in blood, indicating uneven tissue distribution. Blood is the convenient measurement rather than the relevant one for most objectives.
Can I test my NAD+ levels?
Assays exist and some consumer services offer them, but reference ranges are not well established, blood may not reflect the relevant tissue, and sample handling matters because NAD+ degrades. There is no accessible way to measure it in muscle, brain or liver.
What raises NAD+ without supplements?
Exercise increases NAMPT expression in muscle, raising local salvage capacity. Reducing inflammatory load lowers CD38-driven consumption, and avoiding ultraviolet exposure and tobacco smoke reduces PARP-driven consumption.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.